132 related articles for article (PubMed ID: 16305379)
21. Stability of a transdermal salmon calcitonin formulation.
Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
Drug Deliv; 2003; 10(1):41-5. PubMed ID: 12554363
[TBL] [Abstract][Full Text] [Related]
22. Human calcitonin delivery in rats by iontophoresis.
Thysman S; Hanchard C; Préat V
J Pharm Pharmacol; 1994 Sep; 46(9):725-30. PubMed ID: 7837041
[TBL] [Abstract][Full Text] [Related]
23. Iontophoretic transport across a multiple membrane system.
Molokhia SA; Zhang Y; Higuchi WI; Li SK
J Pharm Sci; 2008 Jan; 97(1):490-505. PubMed ID: 17990310
[TBL] [Abstract][Full Text] [Related]
24. Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy.
Li Y; Ju XJ; Fu H; Zhou CH; Gao Y; Wang J; Xie R; Wang W; Liu Z; Chu LY
ACS Appl Mater Interfaces; 2023 Jan; 15(1):638-650. PubMed ID: 36576723
[TBL] [Abstract][Full Text] [Related]
25. Transdermal delivery of regular insulin to chronic diabetic rats: effect of skin preparation and electrical enhancement.
Zakzewski CA; Wasilewski J; Cawley P; Ford W
J Control Release; 1998 Jan; 50(1-3):267-72. PubMed ID: 9685893
[TBL] [Abstract][Full Text] [Related]
26. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
27. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
[TBL] [Abstract][Full Text] [Related]
28. Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber.
Malinovskaja K; Laaksonen T; Hirvonen J
Eur J Pharm Biopharm; 2014 Nov; 88(3):594-601. PubMed ID: 25173088
[TBL] [Abstract][Full Text] [Related]
29. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
Juluri A; Narasimha Murthy S
J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
[TBL] [Abstract][Full Text] [Related]
30. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
[TBL] [Abstract][Full Text] [Related]
31. Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide.
Manosroi J; Lohcharoenkal W; Götz F; Werner RG; Manosroi W; Manosroi A
Drug Dev Ind Pharm; 2013 Apr; 39(4):520-5. PubMed ID: 22564052
[TBL] [Abstract][Full Text] [Related]
32. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
33. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
34. Compartmental modeling of transdermal iontophoretic transport II: in vivo model derivation and application.
Nugroho AK; Della-Pasqua O; Danhof M; Bouwstra JA
Pharm Res; 2005 Mar; 22(3):335-46. PubMed ID: 15835738
[TBL] [Abstract][Full Text] [Related]
35. Delivery of timolol through artificial membranes and pig stratum corneum.
Stamatialis DF; Rolevink HH; Koops GH
J Pharm Sci; 2003 May; 92(5):1037-9. PubMed ID: 12712423
[TBL] [Abstract][Full Text] [Related]
36. Electrically-assisted skin permeation of two synthetic capsaicin derivatives, sodium nonivamide acetate and sodium nonivamide propionate, via rate-controlling polyethylene membranes.
Fang JY; Huang YB; Wang HY; Tsai YH
Biol Pharm Bull; 2005 Sep; 28(9):1695-701. PubMed ID: 16141542
[TBL] [Abstract][Full Text] [Related]
37. Release characteristics of anionic drug compounds from liquid crystalline gels III. Chemical and iontophoretic enhancement of delivery across non-rate-limiting membranes.
Fitzpatrick D; Corish J
Int J Pharm; 2006 Nov; 325(1-2):90-8. PubMed ID: 16963208
[TBL] [Abstract][Full Text] [Related]
38. AC electrokinetic platform for iontophoretic transdermal drug delivery.
Lvovich VF; Matthews E; Riga AT; Kaza L
J Control Release; 2010 Jul; 145(2):134-40. PubMed ID: 20420867
[TBL] [Abstract][Full Text] [Related]
39. Potential of iontophoresis as a drug delivery method for midazolam in pediatrics.
Djabri A; Guy RH; Delgado-Charro MB
Eur J Pharm Sci; 2019 Feb; 128():137-143. PubMed ID: 30503379
[TBL] [Abstract][Full Text] [Related]
40. Passive and iontophoretic transdermal delivery of phenobarbital: Implications in paediatric therapy.
Djabri A; Guy RH; Delgado-Charro MB
Int J Pharm; 2012 Oct; 435(1):76-82. PubMed ID: 22387370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
